Exploring the ATR-CHK1 pathway in the response of doxorubicin-induced DNA damages in acute lymphoblastic leukemia cellsAndrea Ghelli Luserna di Rorà, Giorgia Simonetti, Gerardo Musuraca et al.|Cell Biology and Toxicology|2021Cited by 28
Exploring the role of PARP1 inhibition in enhancing antibody–drug conjugate therapy for acute leukemias: insights from DNA damage response pathway interactionsAndrea Ghelli Luserna di Rorà, Giovanni Martinelli, Mouna Jandoubi et al.|Journal of Translational Medicine|2024Cited by 5
Exploring the ATR-CHK1 Pathway in the Response of Doxorubicin-induced DNA Damages in Acute Lymphoblastic Leukemia CellsAndrea Ghelli Luserna di Rorà, Giorgia Simonetti, Martina Ghetti et al.|Research Square|2021Cited by 3
Abstract 3804: Linear <i>PVT1</i> isoforms and circPVT1 regulate DNA damage response and immunological pathways in acute myeloid leukemia and have a potential role in the crosstalk between leukemic cells and the tumor microenvironmentMartina Ghetti, Giorgia Simonetti, Lorenzo Ledda et al.|Cancer Research|2023Cited by 0
Abstract 5956: <i>FLT3</i> alterations and inhibition in triple negative B-cell adult acute lymphoblastic leukemia patientsAnna Ferrari, Giorgia Simonetti, Andrea Ghelli Luserna di Rorà et al.|Cancer Research|2024Cited by 0